DRUG, NCM

Bright Minds Biosciences Inc. (DRUG)

Price (as of November 2)

0.9897USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

ATHA

Athira Pharma, Inc.

-0.19

FIXX

Homology Medicines, Inc.

-0.14

VRTX

Vertex Pharmaceuticals Incorporated

-0.12

ALBO

Albireo Pharma, Inc.

-0.12

GRAY

Graybug Vision, Inc.

-0.11

GHRS

GH Research PLC

-0.11

CYCC

Cyclacel Pharmaceuticals, Inc.

-0.11

RXRX

Recursion Pharmaceuticals, Inc.

-0.1

CFRX

ContraFect Corporation

-0.1

GMTX

Gemini Therapeutics, Inc.

-0.09

Show more

Highest within Industry

Symbol Correlation

BTTX

Better Therapeutics, Inc.

0.21

BCAB

BioAtla, Inc.

0.21

DRMA

Dermata Therapeutics, Inc.

0.17

CYAD

Celyad Oncology SA

0.16

CALA

Calithera Biosciences, Inc.

0.15

EPIX

ESSA Pharma Inc.

0.14

ANTX

AN2 Therapeutics, Inc.

0.14

IOBT

IO Biotech, Inc.

0.14

BCRX

BioCryst Pharmaceuticals, Inc.

0.13

EDIT

Editas Medicine, Inc.

0.13

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.